The Utilization of Chinese Herbal Products for Hyperthyroidism in National Health Insurance System (NHIRD) of Taiwan: A Population-Based Study.
The Utilization of Chinese Herbal Products for Hyperthyroidism in National Health Insurance System (NHIRD) of Taiwan: A Population-Based Study.
复制标题
DOI：
10.1155/2022/5500604
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
中医可以缓解甲状腺机能亢进的相关症状，如不耐热、心悸、震颤、焦虑、体重减轻、排便频率增加和呼吸急促。但台湾地区对甲状腺机能亢进的方剂及单方的核心处方模式尚无研究。本研究以台湾全民健保研究资料库（NHIRD）为研究对象，以回顾性、观察性的方法分析中医处方模式。此外，还研究了性别、年龄、职业状况、居住区域等人口统计学因素以及甲状腺功能亢进的危险因素。甲状腺机能亢进的门诊和住院服务每年接收17,707例。总共有13394名新诊断的患者。73%的患者使用中药，77.3%的患者为女性。女性患者对中药的接受度较高。大多数患者被诊断为甲状腺功能亢进的年龄在30至49岁之间。最常见的合并症是糖尿病。处方最多的中药制剂为甲味下药散，单处方最多的中药制剂为下苦草。玄参、北母、穆里的配伍率较高。本研究描述台湾地区治疗甲亢的中医核心方剂模式。最常用的CHPs可能是未来药理学研究或临床试验的潜在候选者。
Traditional Chinese Medicine (TCM) relieves associated symptoms of hyperthyroidism such as heat intolerance, palpitations, tremor, anxiety, weight loss, increased frequency of bowel movements, and shortness of breath. However, there are no studies regarding the core prescription patterns of herbal formula and single herbs for hyperthyroidism in Taiwan. This is a retrospective, observational study using the National Health Insurance Research Database (NHIRD) in Taiwan to analyze the prescription patterns of TCM. Demographic factors, such as sex, age, occupational status, and residential area, and the risk factors for hyperthyroidism were also studied. The outpatient or/and inpatient services for hyperthyroidism receive 17,707 cases in a year. Overall, there were 13,394 newly diagnosed patients. TCM was used in 73% of the patients, and 77.3% of the patients were females. The acceptability of TCM was higher among female patients. Most patients were diagnosed with hyperthyroidism between the ages of 30 and 49 years. The most common comorbidity identified was diabetes mellitus. The most commonly prescribed Chinese herbal product (CHP) formula was Jia-Wei-Xia-Yao-San, while Xia-Ku-Cao was the most commonly prescribed single CHP. There was a high coprescription rate for Xuan-Shen, Bei-Mu, and Mu-Li. This study describes the core prescription pattern of TCM used in the treatment of patients with hyperthyroidism in Taiwan. The most frequently used CHPs could be potential candidates for future pharmacologic studies or clinical trials.
登录
查看更多内容
影响因子：
3.2
作者：
Fukao, A;Takamatsu, J;Hanafusa, T
通讯作者：
Hanafusa, T
影响因子：
1.2
作者：
Devereaux, Danielle;Tewelde, Semhar Z.
通讯作者：
Tewelde, Semhar Z.
影响因子：
6.6
作者：
Han, Dong Woo;Koo, Bon Nyeo;Kim, Ki Jun
通讯作者：
Kim, Ki Jun
影响因子：
--
作者：
Chang CC;Chang YC;Hu WL;Hung YC
通讯作者：
Hung YC
DOI：
10.3390/molecules15085093
发表时间：
2010-07-27
期刊：
Molecules (Basel, Switzerland)
影响因子：
--
作者：
Feng L;Jia XB;Shi F;Chen Y
通讯作者：
Chen Y